Recombinant Lactobacillus brevis β-glucuronidase 2A produced by Escherichia coli, is a type of glucuronidase and is responsible for hydrolyzing β-D-glucuronic acid residues from the non-reducing end of mucopolysaccharides.
Expression System
Escherichia coli
Species
Lactobacillus brevis
Concentration
1 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
Glucuronidases
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Lactobacillus brevis β-glucuronidase 2A can be used for liver detoxification and estrogen metabolism research. It has the ability to hydrolyze 4-nitrophenyl-β-D-glucuronide, and β-D-glucuronoside.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
